Lufuradom

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C22H20FN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GS8D070P7W, chemically known as (- )-n-((8-fluoro-2,3-dihydro-1-methyl-5-phenyl-1h-1,4-benzodiazepin-2-yl)-methyl)-3-furamide. but generally known as lufuradom, which bears US NIH Compound Identifier 3045400. European Medicines Agency schedules Lufuradom in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08617MIG. The term LUFURADOM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). LUFURADOM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lufuradom under HS 29349990 and SITC 51579. As of Q4 2014, LUFURADOM remains the US FDA Preferred Term for this commodity. Lufuradom bears US NLM identifiers UMLS ID C2825256 and NCI Concept Code C80563. SMILES: FC1CC2N(C(CN=C(C2CC1)C1CCCCC1)CNC(=O)C1CCOC1)C.